20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
CeriBell, Inc (CBLL) operates in the MEDICAL DEVICES industry and is headquartered in Sunnyvale, United States with about 327 employees. Its market capitalization is roughly $935 million. In the fiscal year ended 2025-12-31, CBLL reported $89M in revenue and ($53M) in net income.
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting.
Interactive charts & full statements → Open the CBLL valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $102M | $89M | $65M | $45M | $26M |
| Gross Profit | $91M | $78M | $57M | $38M | $21M |
| Gross Margin % | 88.9% | 87.9% | 86.7% | 84.4% | 82.9% |
| Operating Income (EBIT) | ($70M) | ($58M) | ($40M) | ($30M) | ($36M) |
| Operating Margin % | -68.6% | -65.6% | -60.7% | -66.4% | -139.0% |
| Net Income | ($66M) | ($53M) | ($40M) | ($29M) | ($37M) |
| Net Margin % | -64.7% | -60.0% | -61.8% | -65.1% | -143.4% |
| EBITDA | ($63M) | ($50M) | ($37M) | ($27M) | ($35M) |
| Earnings Per Share (EPS) | $-1.76 | $-1.46 | $-1.13 | $-1.26 | $-1.59 |
| Shares Outstanding (M) | 38M | 37M | 36M | 23M | 23M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $28M | $26M | $25M | $23M | $21M | $20M | $19M | $17M |
| Gross Profit | $26M | $23M | $22M | $20M | $19M | $18M | $16M | $15M |
| Gross Margin % | 92.3% | 87.3% | 87.3% | 88.3% | 88.1% | 87.9% | 87.6% | 87.3% |
| Operating Income (EBIT) | ($20M) | ($21M) | ($15M) | ($15M) | ($15M) | ($14M) | ($13M) | ($10M) |
| Operating Margin % | -71.1% | -78.3% | -58.9% | -64.8% | -70.5% | -69.3% | -69.5% | -57.8% |
| Net Income | ($19M) | ($20M) | ($14M) | ($13M) | ($14M) | ($13M) | ($13M) | ($10M) |
| Net Margin % | -68.6% | -74.5% | -54.6% | -59.6% | -64.4% | -62.4% | -67.8% | -60.6% |
| EBITDA | ($19M) | ($19M) | ($13M) | ($13M) | ($13M) | ($12M) | ($12M) | ($10M) |
| Earnings Per Share (EPS) | $-0.51 | $-0.52 | $-0.36 | $-0.37 | $-0.38 | $-0.36 | $-0.40 | $-0.31 |
| Shares Outstanding (M) | 38M | 38M | 37M | 37M | 36M | 36M | 31M | 34M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($54M) | ($41M) | ($35M) | ($29M) | ($32M) |
| Capital Expenditures (CapEx) | $2M | $1M | $1M | $1M | $1M |
| Free Cash Flow (FCF) | ($56M) | ($42M) | ($36M) | ($30M) | ($33M) |
| FCF Margin % | -55.2% | -46.7% | -55.6% | -66.6% | -125.4% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($13M) | ($19M) | ($11M) | ($11M) | ($8M) | ($11M) | ($10M) | ($9M) |
| Capital Expenditures (CapEx) | $1M | $1M | $0M | $0M | $0M | $0M | $0M | $1M |
| Free Cash Flow (FCF) | ($14M) | ($20M) | ($11M) | ($11M) | ($8M) | ($12M) | ($10M) | ($9M) |
| FCF Margin % | -49.1% | -75.9% | -44.2% | -50.8% | -35.9% | -57.0% | -55.8% | -53.0% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets | $166M | $196M | $225M | $59M | $86M |
| Cash & Cash Equivalents | $33M | $40M | $194M | $34M | $68M |
| Total Liabilities | $38M | $40M | $34M | $171M | $173M |
| Total Debt (Short + Long-Term) | $21M | $21M | $21M | $13M | $16M |
| Total Shareholders' Equity | $128M | $155M | $191M | ($112M) | ($86M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CBLL viewer.
About TickerBase · Data methodology & sources · Privacy · Terms